PHAR Stock Price Prediction 2026
Pharming Group N.V. ADS, each representing 10 ordinary shares
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.1705)
- Recent pattern: Doji - Indecision pattern
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 21.2% upside potential.
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $20.58 | +0.6% |
| 90 Days | $20.82 | +1.7% |
| 6 Months | $21.18 | +3.5% |
| 1 Year | $21.89 | +6.9% |
| 2 Years EXTENDED | $23.16 | +13.1% |
| 3 Years EXTENDED | $24.50 | +19.7% |
More PHAR Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results